SIRT1 and breast cancer: Sirtuin 1 (SIRT1) is a downstream target of HIF-1α and has been proposed as a potential therapeutic target for OC [315], while SIRT1 increases chemoresistance and metastasis, and its overexpression is connected to BC growth [316,317].